¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"impaired cellular immunity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cellular sensitivity
    ¼¼Æ÷¹Î°¨µµ
  • mixed cellular cast
    È¥ÇÕ¼¼Æ÷¿øÁÖ
  • antibody-mediated immunity
    Ç×ü¸Å°³¸é¿ª
  • antitoxic immunity
    Ç×µ¶¼Ò¸é¿ª
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • athreptic immunity
    ¹«¿µ¾ç¸é¿ª
  • acquired immunity
    ÈÄõ¸é¿ª
  • active immunity
    ´Éµ¿¸é¿ª
  • adoptive immunity
    Â÷¿ë¸é¿ª, ÀÔ¾ç¸é¿ª
  • concomitant immunity
    ¼ö¹Ý¸é¿ª
  • cross immunity
    ±³Â÷¸é¿ª
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª
  • gut immunity
    âÀڸ鿪, Àå°ü¸é¿ª
  • herd immunity
    ¹«¸®¸é¿ª
  • humoral immunity
    ü¾×¸é¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cellular protooncogene
    ¼¼Æ÷¿ø¹ß¾ÏÀ¯ÀüÀÚ
  • cellular radiobiology
    ¼¼Æ÷¹æ»ç¼±»ý¹°ÇÐ
  • cellular sensitivity
    ¼¼Æ÷¹Î°¨µµ
  • cellular type
    ¼¼Æ÷Çü
  • mixed cellular cast
    È¥ÇÕ¼¼Æ÷¿øÁÖ
  • acquired immunity
    ÈÄõ¸é¿ª
  • active immunity
    ´Éµ¿¸é¿ª
  • adoptive immunity
    ÀÔ¾ç¸é¿ª
  • antibody-mediated immunity
    Ç×ü¸Å°³¸é¿ª
  • antitoxic immunity
    Ç×µ¶¼Ò¸é¿ª
  • artificial active immunity
    Àΰø´Éµ¿¸é¿ª
  • athreptic immunity
    ¹«¿µ¾ç¸é¿ª
  • cell-mediated immunity
    ¼¼Æ÷¸Å°³¸é¿ª
  • concomitant immunity
    (¢¡infection immunity) °¨¿°¸é¿ª
  • cross immunity
    ±³Â÷¸é¿ª
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gut immunity
    Àå°ü¸é¿ª
  • herd immunity
    ±ºÁý¸é¿ª, Áý´Ü¸é¿ª
  • herd immunity
    Áý´Ü¸é¿ª, ±ºÁý¸é¿ª, ¹«¸®¸é¿ª
  • immunity, cross
    ±³Â÷¸é¿ª
  • immunity, gut
    Àå°ü¸é¿ª
  • immunity, herd
    Áý´Ü¸é¿ª, ±ºÁý¸é¿ª, ¹«¸®¸é¿ª
  • immunity, humoral
    ü¾×¼º¸é¿ª
  • immunity, innate
    ¼±Ãµ¸é¿ª
  • immunity, local
    ±¹¼Ò¸é¿ª
  • immunity, maternal
    ¸ð¼º¸é¿ª
  • immunity, native
    ¼±Ãµ¸é¿ª
  • immunity, nonspecific
    ºñƯÀ̸鿪
  • immunity, passive
    ¼öµ¿¸é¿ª
  • immunity, protective
    ¹æ¾î¸é¿ª
  • immunity, specific
    ƯÀ̸鿪
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cellular granule
    ¼¼Æ÷°ú¸³
  • cellular hypersensitivity
    ¼¼Æ÷¼º °ú¹Î¹ÝÀÀ
  • cellular hypersensitivity
    ¼¼Æ÷¼º°ú¹Î¹ÝÀÀ
  • cellular infiltration
    ¼¼Æ÷ħÀ±(¡­öÙëÈ).
  • cellular interaction
    ¼¼Æ÷»óÈ£ÀÛ¿ë
  • cellular invagination
    ¼¼Æ÷ÇÔÀÔ
  • cellular islands
    ¼¼Æ÷¼¶
  • cellular layer
    ¼¼Æ÷ÆÇ
  • cellular membrane
    ¼¼Æ÷¼º¸·
  • cellular nevus
    ¼¼Æ÷¼º¸ð¹Ý
  • cellular oncogene
    ¼¼Æ÷¾ÏÀ¯ÀüÀÚ
  • cellular oncogenes
    ¼¼Æ÷¼º Á¾¾çÀ¯ÀüÀÚ
  • cellular process
    ¼¼Æ÷µ¹±â
  • cellular protooncogenes
    ¼¼Æ÷¼º ¿øÁ¾¾çÀ¯ÀüÀÚ
  • cellular radiobiology
    ¼¼Æ÷¹æ»ç¼±»ý¹°ÇÐ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • nonspecific immunity
    ºñƯÀÌ ¸é¿ª(Þª÷åì¶Øóæµ)
  • passive immunity
    ¼öµ¿¸é¿ª(áôÔÑØóæ¹)
  • protective immunity
    º¸È£ ¸é¿ª¼º(ÜÁûÞØóæ¹àõ)
  • specific immunity
    ƯÀ̸鿪(÷åì¶Øóæ¹)
  • superinfection immunity
    Áß°¨¿° ¸é¿ª (ñìÊïæøØóæ¹)
  • transferred immunity
    ÀüÀÌ ¸é¿ª (ï®ì¹Øóæ¹)
  • transplantation immunity
    ÀÌ½Ä ¸é¿ª(ì¹ãÕØóæ¹)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
immun immune, immunity, immunization
IGT Impaired Glucose Tolerance
AIMS abnormal involuntary movement scale; aid for the impaired medical student; arthritis impact measurem...
DWI driving while impaired; driving while intoxicated
EI Edmonton injector; electrolyte imbalance; electron impact; electron ionization; emotionally impaired...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SLI Specifically Language Impaired
HI hearing impaired
I-CAM Inter-Cellular-Adhesion-Molecule
ACR Acute cellular rejection
ADCC Antibody Dependent Cellular Cytotoxicity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • infection immunity
    °¨¿° ¸é¿ª
    ÀÌ¹Ì Ç׿øÀÌ °°°Å³ª °ü·ÃµÈ Ç׿øÀ» °¡Áø ¹Ì»ý¹°¿¡ ÀÇÇÑ ÁúȯÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ Àç°¨¿°¿¡ ´ëÇÏ¿© ÀúÇ×·ÂÀÌ ÀÖ´Â »óÅÂ.
  • local immunity
    ±¹¼Ò ¸é¿ª
  • mucosal immunity
    Á¡¸· ¸é¿ª
  • natural active immunity
    ÀÚ¿¬ ´Éµ¿ ¸é¿ª
  • natural immunity
    ÀÚ¿¬ ¸é¿ª
  • phagocytic immunity
    ½Ä¼¼Æ÷¼º ¸é¿ª
  • racial immunity
    ¹ÎÁ· ¸é¿ª
    À¯ÀüÀûÀ¸·Î °áÁ¤µÇ¾î ÀÖ´Â ÀúÇ×¼ºÀ¸·Î, ¾î¶² Á¾Á· ¸ðµÎ ¶Ç´Â °ÅÀÇ ÀüºÎ°¡ ¾î¶² Á¾·ùÀÇ °£¿°¿¡ ´ëÇÏ¿© ³ªÅ¸³ª´Â ¸é¿ª »óÅÂ.
  • specific humoral immunity
    ƯÀ̼º ü¾× ¸é¿ª
  • transplantation immunity
    ÀÌ½Ä ¸é¿ª
  • acute cellular rejecion
    ±Þ¼º ¼¼Æ÷¼º °ÅºÎ
    ÀϹÝÀûÀ¸·Î ÀÌ½Ä ÈÄ ¼ö °³¿ù ³»¿¡ ¹ß»ýÇϸç Ç÷û Å©·¹¾ÆÆ¼´ÑÄ¡°¡ »ó½ÂÇÏ°í ±Þ¼º ½ÅºÎÀüÀÇ ÀÓ»óÁõ»óÀ» µ¿¹ÝÇÑ´Ù. Á¶Á÷ÇÐÀûÀ¸·Î´Â °£Áú³» ´ÜÇÙ¼¼Æ÷ ħÀ±ÀÌ ¸Å¿ì °­ÇÏ°Ô ³ªÅ¸³ª¸ç, ºÎÁ¾ ¹× °æµµÀÇ °£Áú³» ÃâÇ÷À» º¸À̴µ¥ »ç¶÷ÀÇ °æ¿ì ´ÜÇÙ¼¼Æ÷´Â ÁÖ·Î Áß°£ Å©±â¿Í ÀÛÀº ¸²ÇÁ±¸·Î ±¸¼ºµÇ¾î ÀÖ°í dzºÎÇÑ È£¿°±â¼º ¼¼Æ÷Áú°ú ¼öÆ÷¼º ÇÙÀ» °¡Áø ¼Ò¼öÀÇ ÇüÁú¼¼Æ÷ ħÀ±µµ º¼ ¼ö ÀÖ´Ù.
  • cellular
    ¼¼Æ÷¼º, ¼¼Æ÷ÀÇ
  • cellular adhesiveness
    ¼¼Æ÷ ºÎÂø¼º
    ¼¼Æ÷°£¿¡ ¹°¸®ÀûÀÎ Àη ¶Ç´Â Á¢Ã˹°Ã¼ÀÇ Ç¥¸é°£¿¡ Á¸ÀçÇÏ´Â ºÐÀÚÀη¿¡ ÀÇÇÑ ºÎÂø¼º.
  • cellular antibody
    ¼¼Æ÷ Ç×ü
    ƯÀÌÀûÀÎ ¾Æ¹Ì³ë»ê ¹è¿­À» °¡Áø ¼¼Æ÷¼º ¸é¿ª ±Û·ÎºÒ¸° ºÐÀÚ.
  • cellular axis
    ¼¼Æ÷ Ãà
    ¼¼Æ÷¿¡¼­ ¾î¶² ±¸Á¶¹°À̳ª ȸÀüü°¡ ÁÖÀ§¸¦ µ¹°í ÀÖ´Â Á÷¼±.
  • cellular blue nevus
    ¼¼Æ÷¼º û»ö ¸ð¹Ý
    û»ö ¸ð¹ÝÀÇ Æ¯ÀÌÇÑ º¯ÇüÀ¸·Î¼­ ÀÓ»óÀû ¹× Á¶Á÷ÇÐÀûÀ¸·Î ¾Ç¼º Èæ»öÁ¾À¸·Î ¿ÀÀεDZ⠽±´Ù. À̰ÍÀº µÐºÎ¿Í õ¹Ì°ñ ºÎÀ§¿¡ È£¹ßÇϸç Ä¿´Ù¶õ û»ö ¶Ç´Â Èæ»öÀÇ ´Ü´ÜÇÑ °áÀý·Î ³ªÅ¸³­´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
cellular engineering <technique> The use of techniques for constructing replacement or additional or experimental parts of cells and tissues for both fundamental investigation and as prosthetic devices. Often involves the interfacing of cells and nonliving structures.
(26 Mar 1998)
cellular immune theory A concept, put forth by Elie Metchnikoff, that cells, not antibodies, were responsible for the immune response of an organism.
(05 Mar 2000)
cellular immunodeficiency with abnormal immunoglobulin synthesis An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal.
Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia.
(05 Mar 2000)
cellular infiltration Migration of cells from their sources of origin, or direct extension of cells as a result of unusual growth and multiplication, thereby resulting in fairly well-defined foci, irregular accumulations, or diffusely distributed individual cells in the connective tissue and interstices of various organs and tissues; used especially with reference to such changes associated with inflammations and certain types of malignant neoplasms.
(05 Mar 2000)
cellular microbiology <study> A new discipline emerging at the interface between cell biology and microbiology. One major focus of this new field is on the interference of pathogenic bacteria with many eukaryotic cell functions, such as maturation of intracellular compartments, internal cellular communication, or even cell division and differentiation.
The study of cellular mcirobiology in this respect, is providing a sophisticaled tool kit for mammalian cell biologists.
(26 Mar 1998)
cellular mosaicism A chimerism in which a tissue contains cells from different zygotes; e.g., in humans, involving erythrocytes.
(05 Mar 2000)
cellular oncogene <molecular biology> A normal gene that, when mutated or improperly expressed, can cause cancer to develop.
(09 Oct 1997)
cellular pathology The interpretation of diseases in terms of cellular alterations, i.e., the ways in which cells fail to maintain homeostasis, sometimes used as a synonym for cytopathology.
(05 Mar 2000)
cellular polyp A polyp that consists of benign neoplastic tissue derived from glandular epithelium.
Synonym: cellular polyp, polypoid adenoma.
(05 Mar 2000)
cellular respiration <biochemistry> The conversion within the cell of nutrients (such as sugar molecules) into chemical energy in the form of ATP, by reacting the food with oxygen (O2) until the food has completely been degraded into carbon dioxide and H2O.
(09 Oct 1997)
cellular retinoic acid binding protein <protein> A cytoplasmic fatty acid binding protein that acts as an initial receptor for the putative morphogen, retinoic acid.
(18 Nov 1997)
cellular slime mould See: Acrasidae.
(18 Nov 1997)
cellular tumour A tumour composed mainly of closely packed cells.
(05 Mar 2000)
acquired immunity <immunology> A form of cellular defense which identifies certain foreign substances (antigens) as harmful to the body. For this reason, the body can acquire resistance to a particular foreign agent.
These foreign agents are then attacked by sensitised T lymphocytes (cellular immunity). White blood cells, plasma cells, B lymphocytes and other specialised immune system cells act in concert with T lymphocytes to produce antibodies (humoral immunity) that attach to the antigen directing T-cells to attack.
Antibodies also stimulate the release of special chemical mediators in the blood (for example complement, interferon) that further enhance antigen destruction.
(13 Nov 1997)
active immunity <immunology> An organisms resistance to disease or infection, developed because the organisms immune system has produced antibodies after an infection or innoculation.
(06 May 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á